152 related articles for article (PubMed ID: 27134269)
21. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
22. Prologue: 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Gladman DD
J Rheumatol; 2011 Mar; 38(3):522-5. PubMed ID: 21362779
[TBL] [Abstract][Full Text] [Related]
23. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
Duffin KC; Garg A; Armstrong AW; Helliwell P; Mease PJ
J Rheumatol; 2014 Jun; 41(6):1240-3. PubMed ID: 24882862
[TBL] [Abstract][Full Text] [Related]
24. The Psoriatic Disease Payer Advisory Panel.
Greb JE; Merola J; Garg A; Latella J; Howard L; Acharya N; Gottlieb AB
J Drugs Dermatol; 2016 May; 15(5):641-4. PubMed ID: 27168273
[TBL] [Abstract][Full Text] [Related]
25. Summary of minutes of the GRAPPA meeting adjacent to the American Academy of Dermatology 67th Annual Meeting.
Boehncke WH; Gottlieb AB; Krueger GG; Qureshi AA; Garg A
J Rheumatol; 2011 Mar; 38(3):553-6. PubMed ID: 21362786
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
[TBL] [Abstract][Full Text] [Related]
28. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
[TBL] [Abstract][Full Text] [Related]
29. Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting.
Perez-Chada LM; Kohn A; Gottlieb AB; Armstrong AW; Eder L; Mease PJ; Ogdie A; Strand V; Merola JF
J Rheumatol; 2021 Mar; ():. PubMed ID: 33722941
[TBL] [Abstract][Full Text] [Related]
30. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.
Chandran V; Maharaj AB
Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494
[TBL] [Abstract][Full Text] [Related]
31. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Boehncke WH; Gladman DD
J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533
[TBL] [Abstract][Full Text] [Related]
32. Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting.
Gottlieb AB; Armstrong AW
J Rheumatol; 2013 Aug; 40(8):1428-33. PubMed ID: 23908539
[TBL] [Abstract][Full Text] [Related]
33. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
Villacorta R; Hay JW; Messali A
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
[TBL] [Abstract][Full Text] [Related]
34. Outcome measures in psoriatic arthritis.
Gladman DD; Mease PJ; Krueger G; van der Heidje DM; Antoni C; Helliwell PS; Kavanaugh AF; Nash P; Ritchlin CT; Strand CV; Taylor W
J Rheumatol; 2005 Nov; 32(11):2262-9. PubMed ID: 16265714
[TBL] [Abstract][Full Text] [Related]
35. The assessment of disease activity and outcomes in psoriatic arthritis.
Kavanaugh A; Cassell S
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S142-7. PubMed ID: 16273798
[TBL] [Abstract][Full Text] [Related]
36. MANAGEMENT OF PSORIATIC ARTHRITIS: SHOULD THE INTERACTION BETWEEN DERMATOLOGISTS AND RHEUMATOLOGISTS IN CLINICAL PRACTICE BE INTENSIFIED?
Migliore A; Cusano F; Bianchi G; Malara G; Epis O; De Pità O
J Biol Regul Homeost Agents; 2015; 29(3):547-61. PubMed ID: 26403393
[TBL] [Abstract][Full Text] [Related]
37. Skin therapies: dermatologic perspective on the rheumatology-dermatology interface.
Sasaki JL; Koo JY
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S78-81. PubMed ID: 26472228
[TBL] [Abstract][Full Text] [Related]
38. Assessment tools in psoriatic arthritis.
Mease PJ
J Rheumatol; 2008 Jul; 35(7):1426-30. PubMed ID: 18609738
[TBL] [Abstract][Full Text] [Related]
39. Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study.
Cañete JD; Daudén E; Queiro R; Aguilar MD; Sánchez-Carazo JL; Carrascosa JM; Carretero G; García-Vivar ML; Lázaro P; López-Estebaranz JL; Montilla C; Ramírez J; Rodríguez-Moreno J; Puig L
Actas Dermosifiliogr; 2014 Apr; 105(3):216-32. PubMed ID: 24657018
[TBL] [Abstract][Full Text] [Related]
40. Multidisciplinary psoriasis and psoriatic arthritis unit: report of 4 years' experience.
Luelmo J; Gratacós J; Moreno Martínez-Losa M; Ribera M; Romaní J; Calvet J; Leal L; Larrosa M
Actas Dermosifiliogr; 2014 May; 105(4):371-7. PubMed ID: 24360030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
